# Nocion Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nocion-therapeutics

- Industry: Biotechnology
- Headquarters: Watertown, US
- Website: www.nociontx.com/
- Total disclosed funding: $58M
- Latest round: Series B (Feb 29, 2024)
- Investors on record: 7

## About

Based in Massachusetts, US, and Founded in 2017 by co-founders Bruce Levy MD, Clifford Woolf Ph.D, and Bruce Bean Ph.D, Nocion Therapeutics, Inc. operates as a provider of various therapies for neurogenic inflammation conditions, offering solutions to patients with pain, cough, itch, and inflammation. In February 2024, Nocion Therapeutics, Inc. raised USD 31.11 million in series B funding co-led by Arkin Holdings and Monograph Capital Partners, with participation Canaan Partners, F-Prime Capital, Mass General Brigham Ventures, Mission BioCapital, and OUP (Osage University Partners. As of 2024, the company is led by its CEO, Richard Batycky Ph.D.

The company provides a wide range of biopharmaceutical products, such as nocions, which selectively affect activated sensory neurons to treat conditions like chronic cough, pain, itch, and inflammation. Nocions block sodium channels in inflamed nociceptors, providing long-acting relief. Additionally, the firm also provides therapies targeting various indications in pulmonology, gynecology, urology, dermatology, gastroenterology, and ophthalmology.

## Funding rounds

- Series B, Feb 29, 2024, $31M — Canaan Partners, OUP (Osage University Partners), F-Prime Capital, Mass General Brigham Ventures, Mission Biocapital, Arkin Capital, Monograph Capital
- Series A, Apr 17, 2019, $27M — Canaan Partners, F-Prime Capital, Mass General Brigham Ventures, Mission Biocapital

## Investors

- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series A, Series B
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series A, Series B
- Mass General Brigham Ventures (https://capitalatlas.ai/funds/mass-general-brigham-ventures) — Series A, Series B
- Mission Biocapital (https://capitalatlas.ai/funds/mission-biocapital) — Series A, Series B
- OUP (Osage University Partners) (https://capitalatlas.ai/funds/oup-osage-university-partners) — Series B
- Arkin Capital (https://capitalatlas.ai/funds/arkin-capital) — Series B
- Monograph Capital (https://capitalatlas.ai/funds/monograph-capital) — Series B